Fecal analyses and necropsies suggest a fire-footed rope squirrel was the source of a 2023 mpox outbreak among sooty ...

During a test drive, the mobile lab van uncovered a drug-resistant HIV strain that sprung up after the ongoing war with Russia started.

Pancreatic cancer continues to be a devastating disease, with an overall 5-year survival rate of around 13%. Accounting for about 3% of all cancers, it is the third leading cause of cancer death in ...

Larry Carbone offers an insider's perspective on the ethics of using animals in invasive research, the need for more compassion, and what must be done immediately on their behalf.

Thomas Kuhn, the 20th-century historian of science who coined the phrase “paradigm shift,” had a name for such breakdowns in ...

Nourish, a virtual nutrition provider, is launching a program that gives patients access to free cardiometabolic lab testing. Nourish Labs will integrate blood testing into personalized nutrition care ...

Rapid advances in cutting-edge innovative drugs, particularly the expansion of large-molecule therapeutics, is casting a spotlight on the importance on key upstream experimental resources for such ...

Rocket Lab Corporation (RKLB) announced that its Neutron rocket's Stage 1 tank ruptured during a hydrostatic pressure trial. The company noted that testing failures are not uncommon during ...

NORTH PHILADELPHIA (WPVI) -- There's a potential new treatment for severe emphysema, and Philadelphia is a key test site for this small device with big potential to improve lives. In COPD (Chronic ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect Alzheimer's disease at its very earliest stage, even before symptoms appear.

Labcorp is adding to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging. The line includes the company’s Plasma Detect ID, a whole exome sequence-guided, ...

Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA ...